Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2026-01-04 @ 12:21 PM
Study NCT ID:
NCT01284868
Status:
COMPLETED
Last Update Posted:
2013-07-03
First Post:
2011-01-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
Sponsor:
Astellas Pharma Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
178-CL-053
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Disclosure Office Europe
Old Organization:
Astellas Pharma Europe BV